Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shankari Mylvaganam"'
Autor:
K. Darrell Berlin, Richard A. Bunce, Baskar Nammalwar, William W. Barrow, Shankari Mylvaganam, Philip C. Bourne, Christina R. Bourne, Esther W. Barrow, Nancy Wakeham, Kal Ramnarayan
Publikováno v:
ChemMedChem. 7:1974-1982
A series of (±)-6-alkyl-2,4-diaminopyrimidine-based inhibitors of bacterial dihydrofolate reductase (DHFR) have been prepared and evaluated for biological potency against Bacillus anthracis and Staphylococcus aureus. Biological studies reveal attenu
Autor:
Mark D. Shenderovich, Cindy L. Fisher, Vladimir Tseitin, Michael J. Dudek, S. McDonald, Muthuchidambaram Prabhakaran, Kal Ramnarayan, Shankari Mylvaganam, R. Kodandapani, Jian Hua Zheng, G. Raghunathan
Publikováno v:
Current Proteomics. 2:233-258
Autor:
Christina R. Bourne, Esther W. Barrow, Vladimir Tseitin, Kal Ramnarayan, K. Darrell Berlin, William W. Barrow, Philip C. Bourne, Richard A. Bunce, Nancy Wakeham, Baskar Nammalwar, Shankari Mylvaganam
Background: Bacterial resistance to antibiotic therapies is increasing and new treatment options are badly needed. There is an overlap between these resistant bacteria and organisms classified as likely bioterror weapons. For example, Bacillus anthra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4365355cfa9cfeee643025baf14bbf
https://europepmc.org/articles/PMC3530638/
https://europepmc.org/articles/PMC3530638/
Autor:
Richard A. Bunce, Nancy Wakeham, Baskar Nammalwar, Kal Ramnarayan, K. Darrell Berlin, William W. Barrow, Christina R. Bourne, Esther W. Barrow, Shankari Mylvaganam, Philip C. Bourne
Publikováno v:
ChemMedChem. 7:1866-1866